Provided by Tiger Trade Technology Pte. Ltd.

Achieve Life Sciences, Inc.

7.04
-0.2400-3.30%
Volume:909.05K
Turnover:6.47M
Market Cap:722.72M
PE:-4.24
High:7.44
Open:7.38
Low:7.01
Close:7.28
52wk High:8.64
52wk Low:2.62
Shares:102.66M
Float Shares:74.69M
Volume Ratio:0.64
T/O Rate:1.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6600
EPS(LYR):-1.2535
ROE:-844.99%
ROA:-29.21%
PB:-49.25
PE(LYR):-5.62

Loading ...

Achieve Life Sciences Inc - Appoints Andrew D. Goldberg as CEO and Board Member Effective After Closing

THOMSON REUTERS
·
Apr 16

Achieve Life Sciences - Proceeds to Fund Phase 3 Clinical Trial for Cytisinicline for E-Cigarette Cessation, Commercialization of Cytisinicline

THOMSON REUTERS
·
Apr 16

Achieve Life Sciences Announces up to $354 Million Private Placement

THOMSON REUTERS
·
Apr 16

Achieve Life Sciences Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 16

Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV), CareDx (CDNA) and Astrana Health (ASTH)

TIPRANKS
·
Apr 16

Achieve Life Sciences Shares Fall After FDA Inspection Finds Violations

Dow Jones
·
Apr 15

Achieve expects FDA complete response letter after OAI at third-party drug plant

Reuters
·
Apr 15

Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions

THOMSON REUTERS
·
Apr 15

Achieve Life Sciences Inc - Transfers Cytisinicline Manufacturing to Adare Pharma Solutions

THOMSON REUTERS
·
Apr 15

Achieve Life Sciences Flags FDA Observations While Pushing Launch To 2027 For Smoking Cessation Med

Benzinga_recent_news
·
Mar 26

Achieve Life Sciences announces Nicotine & Tobacco Research study; cytisinicline shows 99% α4β2 receptor binding on low nausea risk due to -8% 5-HT3 displacement

Reuters
·
Mar 26

Achieve Life Sciences Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 25

Execution Risks Cloud Achieve Life Sciences’ Commercial Plans for Cytisinicline

TIPRANKS
·
Mar 25

Achieve Life Sciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 24

Achieve Life Sciences Q4 EPS $(0.28) Misses $(0.27) Estimate

Benzinga Earnings
·
Mar 24

Achieve Life Sciences Q4 EPS USD -0.28 VS. Ibes Estimate USD -0.27

THOMSON REUTERS
·
Mar 24

Achieve Life Sciences Q4 net loss rises 19% to USD 15 million

Reuters
·
Mar 24

Achieve Life Sciences Inc - Anticipates U.S. Commercial Launch in First Half of 2027

THOMSON REUTERS
·
Mar 24

Achieve Life Sciences Inc - Q4 Net Loss $14.7 Mln, FY2025 Net Loss $54.7 Mln

THOMSON REUTERS
·
Mar 24

Achieve Life Sciences Inc - Announces Partnership With Adare Pharma Solutions for Cytisinicline Manufacturing

THOMSON REUTERS
·
Mar 24